KZRKezar Life Sciences Inc
KZR
Kezar Life Sciences Inc1,728
Mkt Cap
$54.03MVolume
57,308.0052W High
$7.5552W Low
$3.53PE Ratio
-0.96KZR Fundamentals
Price
$7.33Prev Close
$7.31Open
$7.2650D MA
$7.06Beta
0.93Avg. Volume
93,151.70EPS (Annual)
-$7.66P/B
0.77Rev/Employee
$0.00$23.53
Kezar Life Sciences, Inc. (NASDAQ:KZR) Sees Large Decrease in Short Interest
Kezar Life Sciences, Inc. (NASDAQ:KZR - Get Free Report) was the recipient of a large decline in short interest during the month of April. As of April 15th, there was short interest totaling 151,602 shares, a decline of 24.7% from the March 31st total of 201,330 shares. Based on an average daily...
MarketBeat·3d ago
Are KZR, EQH, ULYX Obtaining Fair Deals for their Shareholders?
Are KZR, EQH, ULYX Obtaining Fair Deals for their Shareholders? Are KZR, EQH, ULYX Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, April 14, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may...
PR Newswire·18d ago
Are APLS, CNTA, KZR Obtaining Fair Deals for their Shareholders?
Are APLS, CNTA, KZR Obtaining Fair Deals for their Shareholders? Are APLS, CNTA, KZR Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, April 10, 2026 Insiders may stand to receive...
PR Newswire·23d ago
Kezar Life Sciences, Inc. (NASDAQ:KZR) Given Average Recommendation of "Reduce" by Brokerages
Kezar Life Sciences, Inc. (NASDAQ:KZR - Get Free Report) has been given an average recommendation of "Reduce" by the six ratings firms that are covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell rating and four have assigned a hold rating to the...
MarketBeat·23d ago
SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--KZR, CNTA, AFBI, and APLS
SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--KZR, CNTA, AFBI, and APLS SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--KZR, CNTA, AFBI, and APLS...
PR Newswire·25d ago
Are KZR, TALK, WBD Obtaining Fair Deals for their Shareholders?
Are KZR, TALK, WBD Obtaining Fair Deals for their Shareholders? Are KZR, TALK, WBD Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, April 7, 2026 Insiders may stand to receive...
PR Newswire·26d ago
Are KZR, NSA, EQH, CTRA Obtaining Fair Deals for their Shareholders?
Are KZR, NSA, EQH, CTRA Obtaining Fair Deals for their Shareholders? Are KZR, NSA, EQH, CTRA Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, March 31, 2026 Insiders may stand to...
PR Newswire·1mo ago
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Kezar Life Sciences, Inc. (NASDAQ: KZR)
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Kezar Life Sciences, Inc. (NASDAQ: KZR) $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Kezar...
PR Newswire·1mo ago
Shareholder Alert: The Ademi Firm investigates whether Kezar Life Sciences, Inc. is obtaining a Fair Price for Public Shareholders
Shareholder Alert: The Ademi Firm investigates whether Kezar Life Sciences, Inc. is obtaining a Fair Price for Public Shareholders Shareholder Alert: The Ademi Firm investigates whether Kezar Life...
PR Newswire·1mo ago
KZR Stock Alert: Halper Sadeh LLC is Investigating Whether Kezar Life Sciences, Inc. is Obtaining a Fair Price for its Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Kezar Life Sciences, Inc. (NASDAQ: KZR) to Aurinia Pharmaceuticals Inc. for $6.955 in cash per share and one non-transferable contingent value right. Halper Sadeh encourages Kezar shareholders to click here to learn more...
Business Wire·1mo ago
<
1
2
...
>